| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/25/2012 | US20120269767 Treatment of Neurodegenerative Diseases |
| 10/25/2012 | US20120269766 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| 10/25/2012 | US20120269765 Cytokine compositions and methods of use thereof |
| 10/25/2012 | US20120269764 RBM3 as a Marker for Malignant Melanoma Prognosis |
| 10/25/2012 | US20120269763 Compositions and methods for reducing the risk of preterm labor |
| 10/25/2012 | US20120269762 Causal therapy of diseases or conditions associated with cns or pns demyelination |
| 10/25/2012 | US20120269734 Self-Illuminating Dot Systems and Methods of Use Thereof |
| 10/25/2012 | US20120269733 Model Systems and Treatment Regimes for Treatment of Neurological Disease |
| 10/25/2012 | US20120269731 Polypeptides that home to atherosclerotic plaque |
| 10/25/2012 | DE102008049136B4 Neue Regulatoren des angeborenen Immunsystems New regulators of the innate immune system |
| 10/24/2012 | EP2514824A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
| 10/24/2012 | EP2514823A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
| 10/24/2012 | EP2514768A1 Fusion polypeptide against eb virus-induced tumor and colicin ia mutant |
| 10/24/2012 | EP2514763A1 Egf receptor epitope peptides and uses thereof |
| 10/24/2012 | EP2514762A2 B7-DC variants |
| 10/24/2012 | EP2514761A1 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
| 10/24/2012 | EP2514760A1 Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability |
| 10/24/2012 | EP2514473A1 Nitric oxide delivery device |
| 10/24/2012 | EP2514445A2 Bioactive hydrogel compositions |
| 10/24/2012 | EP2514436A2 Compositions and methods for treatment of microbial disorders |
| 10/24/2012 | EP2514435A1 Infant formula for use in the prevention of cardiovascular diseases |
| 10/24/2012 | EP2514434A2 MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
| 10/24/2012 | EP2514433A2 MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
| 10/24/2012 | EP2514412A1 Highly Concentrated Insulin Solutions and Compositions |
| 10/24/2012 | EP2514407A1 Stable non-aqueous pharmaceutical compositions |
| 10/24/2012 | EP2514406A1 Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier |
| 10/24/2012 | EP2513313A1 Substances and methods for the treatment of lysosmal storage diseases |
| 10/24/2012 | EP2513141A2 Glp-1 analogues and derivatives |
| 10/24/2012 | EP2513137A2 Saposin-a derived peptides and uses thereof |
| 10/24/2012 | EP2512510A1 A novel vaccine that targets tumor vessels as an efficient tool in tumor therapy |
| 10/24/2012 | EP2512507A1 Treatment of nasal and sinus disorders |
| 10/24/2012 | EP2512505A2 Modified clostridial toxins comprising an integrated protease cleavage site-binding domain |
| 10/24/2012 | EP2512504A1 Treatment composition and method |
| 10/24/2012 | EP2512503A2 Glucagon/glp-1 receptor co-agonists |
| 10/24/2012 | EP2512502A2 Methods and compositions for liquidation of tumors |
| 10/24/2012 | EP2512501A2 Hair growth methods using fgfr3 extracellular domains |
| 10/24/2012 | EP2512500A1 Therapeutic uses of soluble alpha-klotho |
| 10/24/2012 | EP2512499A1 Use of a neurofilament peptide for the treatment of glioma |
| 10/24/2012 | EP2512498A2 Peptide protection against ultraviolet light toxicity |
| 10/24/2012 | EP2512497A1 Methods and compositions related to clot-binding compounds |
| 10/24/2012 | EP2512496A1 Peptide |
| 10/24/2012 | EP2512477A1 Hcv combination therapy |
| 10/24/2012 | EP2512450A2 Dry growth hormone composition transiently linked to a polymer carrier |
| 10/24/2012 | CN102753690A Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders |
| 10/24/2012 | CN102753683A Protein having cedar pollen immunogenicity, polynucleotide for coding for said protein, and uses of said protein and polynucleotide |
| 10/24/2012 | CN102753576A Apolipoprotein a-1 mimic peptides, and therapeutic agent for treating hyperlipidemia and diseases related to hyperlipidemia comprising same |
| 10/24/2012 | CN102753574A Novel conjugates and compositions for immunotherapy and antineoplastic treatment |
| 10/24/2012 | CN102753192A Pharmaceutical composition for treating a metabolic syndrome |
| 10/24/2012 | CN102753191A Treatment and prevention of cancers associated with intracellular oncoproteins by antibody therapy or vaccination |
| 10/24/2012 | CN102753173A Hcv combination therapy |
| 10/24/2012 | CN102753153A Topical ophthalmic peptide formulation |
| 10/24/2012 | CN102753150A Pharmaceutical compositions for oral administration of insulin peptides |
| 10/24/2012 | CN102753147A Liquid formulations for long-acting erythropoietin conjugate |
| 10/24/2012 | CN102753146A Orally administrable pharmaceutical pellet of epidermal growth factor |
| 10/24/2012 | CN102753043A Nutritional compositions and methods for optimizing dietary acid-base potential |
| 10/24/2012 | CN102747046A Construction method and application of oncolytic adenovirus targeting CD123 positive leukemia cell |
| 10/24/2012 | CN102747039A Tumor-associated antigen, monoclonal antibody and purpose thereof |
| 10/24/2012 | CN102746386A Polypeptide for preventing and treating cell proliferative disorders |
| 10/24/2012 | CN102746385A Thymosin alpha 1 active fragment cyclopeptide analogue and polyethylene glycol derivative thereof |
| 10/24/2012 | CN102746384A High purity caspofungin or its salt and its preparation method and application |
| 10/24/2012 | CN102746380A Application of angiogenesis inhibitor polypeptide to preparation of medicine for treating tumor and rheumatoid arthritis |
| 10/24/2012 | CN102746378A Anti-fatty acid synthetase polypeptide and its application |
| 10/24/2012 | CN102746376A Cyclopeptide antibiotics and preparation method thereof and application of cylopeptide antibiotics in preparation of antibacterial agents |
| 10/24/2012 | CN102743744A Applications of alliinase, and medicinal composition |
| 10/24/2012 | CN102743743A Health-care product used for onychomycosis |
| 10/24/2012 | CN102743742A Glycoprotein composition with low solvent residues, its preparation and its application |
| 10/24/2012 | CN102743741A Preparation of blattodea polypeptide, and uses of the same in anti-gram-positive bacteria and anti-gram-negative bacteria |
| 10/24/2012 | CN102743740A Compositions for nasal delivery |
| 10/24/2012 | CN102743739A Preparation method for blattodea polypeptide substance, and medical use of blattodea polypeptide substance in anti-herpesvirus |
| 10/24/2012 | CN102743568A Traditional Chinese medicine composite for treating acute gangrenous stomatitis |
| 10/24/2012 | CN102743412A Application of viable cells for improving skin appearance |
| 10/24/2012 | CN102743339A Alkaline phosphatase micro-/nano-particle and preparation method thereof |
| 10/24/2012 | CN102389392B Recombinant bovine basic fibroblast growth factor gel for eye use |
| 10/24/2012 | CN102212539B Efficiently expressed series porcine alpha and gamma interferon genes and application of expressed protein thereof |
| 10/24/2012 | CN102133230B Compound mactra veneriformis organic calcium preparation and preparation method thereof |
| 10/24/2012 | CN102091056B Cell microcapsule for treating parkinsonism and composite cytoskeleton |
| 10/24/2012 | CN102058620B Fistula affused liquid medicine for anal fistula |
| 10/24/2012 | CN102026669B Application of conjugates for the treatment of mesothelioma |
| 10/24/2012 | CN102008713B Ciclosporin A proliposome, pharmaceutical composition and preparation method thereof |
| 10/24/2012 | CN101966171B Hydrosoluble reduced enzyme Q10 composition and preparation method thereof |
| 10/24/2012 | CN101469329B Compositions and methods for increasing bone mineralization |
| 10/24/2012 | CN101337989B Novel glucagon-like peptide-1(GLP-1) analogues and use thereof |
| 10/24/2012 | CN101065401B Osteoprotegerin variant proteins |
| 10/24/2012 | CN101065131B Antimicrobial agents |
| 10/23/2012 | US8293979 Weed controller metabolism proteins, genes, thereof and use of the same |
| 10/23/2012 | US8293873 Combination of amino acid solution and a gelatin derivative for inhibiting renal up-take |
| 10/23/2012 | US8293871 Poly(lactide-co-glycolide) based sustained release microcapsules comprising a polypeptide and a sugar |
| 10/23/2012 | US8293869 Polymer conjugates of GLP-1 |
| 10/23/2012 | US8293745 Use of imatinib to treat liver disorders and viral infections |
| 10/23/2012 | US8293717 Materials and methods for prevention and treatment of RNA viral diseases |
| 10/23/2012 | US8293714 Anti-angiogenic compounds |
| 10/23/2012 | US8293713 Beta-turn peptidomimetic cyclic compounds for treating dry eye |
| 10/23/2012 | US8293712 Cosmetic composition for stimulating the synthesis of proteins of the basement membrane |
| 10/23/2012 | US8293711 Use of natriuretic peptides for treating angioedema syndromes |
| 10/23/2012 | US8293710 Method for treating wounds using an EGF-like domain of thrombomodulin |
| 10/23/2012 | US8293709 Growth hormone fusion proteins |
| 10/23/2012 | US8293708 Liquid formulations N-terminal serine of pegylated growth hormone |
| 10/23/2012 | US8293707 Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for increasing FSH activity |
| 10/23/2012 | US8293706 Method for inhibiting release of hepatitis B virus from liver cells |
| 10/23/2012 | US8293705 HCV protease inhibitors and uses thereof |